The FDA and the DEA abandoned the “gateway theory” in August 2016 Newsflash: the “gateway theory” is no longer official government doctrine There is much concern in the cannabis legalization movement/industry that the new administration will go to war against the legal cannabis markets. The nomination of Alabama Senator Jeff Sessions, recent comments… Read More Vaporizing cannabis prohibition: the gateway theory is gone
Gonzalez Franco predicted technology would allow users to experience mind-altering hallucinations that often occur under the influence of psychedelic drugs but without all the dismal side effects of taking a substance like LSD. from an International Business Times article on a new product line from Microsoft. Dismal side effects of taking a substance like LSD. Like…a lower… Read More Virtual reality and psychedelic prohibition
Change federal drug law to require that the DEA consider whether states accept that there is a medical use for cannabis Back in October of 2012 I published an explanation of the DEA’s legal justification for permanent cannabis prohibition and how to attack it. I explained that the DEA misconstrues the Controlled Substances Act (the “CSA”), the federal statute that governs… Read More Vaporizing cannabis prohibition under Trump: make the DEA defer to state law
The following video is relevant to people who advocate for psychedelic legalization. Cannabis lawyer Hilary Bricken posits that (a) state-level regulatory factors have given rise to “Big Marijuana,” the for-profit industry that requires deep capitalization and therefore monopoly (functional or actual) and (b) the prohibitionist movement (which is not dead, just dormant waiting for the opportunity to reassert… Read More Big Acid
The Imperial College of London just announced that a small safety trial of twelve patients with moderate to severe treatment-resistant depression shows that psilocybin can be administered safely and can relieve symptoms of depression for up to five months. The article states that 350 million people around the world (that’s all?) suffer from depression. Other than safety the purpose of… Read More Psychedelic prohibition as restraint-of-trade: results from a limited trial of psilocybin for treatment-resistant depression
The press release is the summary of a study authored by researchers at Columbia University: Variation in medical marijuana program regulations impacts enrollment: A study published today in Health Affairs found that while 14 of the nation’s 24 medical marijuana programs were essentially nonmedical in practice, they enrolled more than 99 percent of overall participants. Fewer than one… Read More "Medical marijuana" programs have few patients – and why is that?
I note that LSD microdosing is trending, if only a little bit (see the recent articles in Rolling Stone and the Huffington Post). Microdosing is the practice of taking extremely low doses of LSD during the regular work week for the purposes of increasing functionality, in a sense like a performance-enhancing supplement – indeed, the… Read More The dose makes the poison – LSD microdosing